High Prevalence of Renal Dysfunction and Its Impact on Outcome in 118,465 Patients Hospitalized With Acute Decompensated Heart Failure: A Report From the ADHERE Database

Journal of Cardiac Failure

Volumn 13, Issue 6, 2007, Pages 422-430

  Heywood, J Thomas ^a   Fonarow, Gregg C ^b   Costanzo, Maria Rosa ^c   Mathur, Vandana S ^d   Wigneswaran, John R ^e   Wynne, Janet ^e  

^a SCRIPPS CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Midwest Heart Specialists   (United States)

^d Mathur Consulting   (United States)

^e SCIOS INC   (United States)

Author keywords

Heart failure; Registries; Renal insufficiency; Risk assessment

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUMETANIDE; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; FUROSEMIDE; MILRINONE; NESIRITIDE; NITRIC ACID DERIVATIVE; TORASEMIDE;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIALYSIS; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL;

ACUTE DISEASE; AGED; CARDIAC OUTPUT, LOW; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; MORBIDITY; PREVALENCE; PROGNOSIS; REGISTRIES; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; UNITED STATES;

EID: 34547542423     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2007.03.011     Document Type: Article

References (34)

1. DeFrances C.J., and Hall M.J. 2002 National Hospital Discharge Survey. Adv Data (2004) 1-29
2. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult-Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 112 (2005) 1825-1852
3. Bakris G.L., and Weir M.R. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?. Arch Intern Med 160 (2000) 685-693
4. Nieminen M.S., Böhm M., Cowie M.R., Drexler H., Filippatos G.S., Jondeau G., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 384-416
5. Swedberg K., Cleland J., Dargie H., Drexler H., Follath F., Komajda M., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
6. Kittleson M., Hurwitz S., Shah M.R., Nohria A., Lewis E., Givertz M., et al. Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality. J Am Coll Cardiol 41 (2003) 2029-2035
7. Schoolwerth A.C., Sica D.A., Ballermann B.J., and Wilcox C.S. Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Circulation 104 (2001) 1985-1991
8. Hillege H.L., Girbes A.R.J., de Kam P.J., Boomsma F., de Zeeuw D., Charlesworth A., et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102 (2000) 203-210
9. Fonarow G.C., Adams Jr. K.F., Abraham W.T., Yancy C.W., and Boscardin W.J. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293 (2005) 572-580
10. Levey A.S., Coresh J., Balk E., Kausz A.T., Levin A., Steffes M.W., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139 (2003) 137-147
11. Adams K.F., Fonarow G.C., Emerman C.L., LeJemtel T.H., Costanzo M.R., Abraham W.T., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design and preliminary observations from the Acute Decompensated Heart Failure National Registry (ADHERE®). Am Heart J 149 (2005) 209-216
12. Abraham W.T., Adams K.F., Fonarow G.C., Costanzo M.R., Berkowitz R.L., LeJemtel T.H., et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the ADHERE registry. J Am Coll Cardiol 46 (2005) 57-64
13. Fonarow G.C., Yancy C.W., and Heywood J.T. Adherence to Heart Failure Quality-of-Care Indicators in US Hospitals: analysis of the ADHERE Registry. Arch Intern Med 165 (2005) 1469-1477
14. Redfield M.M. Heart failure-an epidemic of uncertain proportions. N Engl J Med 347 (2002) 1442-1444
15. Coresh J., Astor B.C., Greene T., Eknoyan G., and Levey A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 (2003) 1-12
16. United States Renal Data System. USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States (2005), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
17. Cooper W.A., O'Brien S.M., Thourani V.H., Guyton R.A., Bridges C.R., Szczech L.A., et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 113 (2006) 1063-1070
18. Palmer B.F. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and/or serum potassium concentration rises. Nephrol Dial Transplant 18 (2003) 1973-1975
19. Sackner-Bernstein J.D., Skopicki H.A., and Aaronson K.D. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111 (2005) 1487-1491
20. Mentzer R.M., Mehmet C., Sladen R.N., Graeve A.H., Hebeler R.F., Luber J.M., et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: The NAPA trial. J Am Coll Cardiol 49 (2007) 716-726
21. Cohn J.N., and Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345 (2001) 1667-1675
22. Yusuf S., Pfeffer M.A., Swedberg K., Granger C.B., Held P., McMurray J.J., et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362 (2003) 777-781
23. Bibbins-Domingo K., Lin F., Vittinghoff E., Barrett-Connor E., Grady D., and Shlipak M.G. Renal insufficiency as an independent predictor of mortality among women with heart failure. J Am Coll Cardiol 44 (2004) 1593-1600
24. Williams S.C., Koss R.G., Morton D.J., and Loeb J.M. Performance of top-ranked heart care hospitals on evidence-based process measures. Circulation 114 (2006) 558-564
25. Cowie M.R., Komajda M., Murray-Thomas T., Underwood J., and Ticho B. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 27 (2006) 1216-1222
26. Forman D.E., Butler J., Wang Y., Abraham W.T., O'Connor C.M., Gottlieb S.S., et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43 (2004) 61-67
27. Gottlieb S.S., Brater D.C., Thomas I., Havranek E., Bourge R., Goldman S., et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 105 (2002) 1348-1353
28. Krumholz H.M., Chen Y.T., Vaccarino V., Wang Y., Radford M.J., Bradford W.D., et al. Correlates and impact on outcomes of worsening renal function in patients 65 years of age with heart failure. Am J Cardiol 85 (2000) 1110-1113
29. Smith G.L., Vaccarino V., Kosiborod M., Lichtman J.H., Cheng S., Watnick S.G., et al. Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure?. J Card Fail 9 (2003) 13-25
30. Aronson D., Mittleman M.A., and Burger A.J. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med 116 (2004) 466-473
31. Lee D.S., Austin P.C., Rouleau J.L., Liu P.P., Naimark D., and Tu J.V. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 290 (2003) 2581-2587
32. Heywood J.T., Elatre W., Pai R.G., Fabbri S., and Huiskes B. Simple clinical criteria to determine the prognosis of heart failure. J Cardiovasc Pharmacol Ther 10 (2005) 173-180
33. Smith G.L., Lichtman J.H., Bracken M.B., Shlipak M.G., Phillips C.O., DiCapua P., et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47 (2006) 1987-1996
34. Hillege H.L., Nitsch D., Pfeffer M.A., Swedberg K., McMurray J.J., Yusuf S., et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113 (2006) 671-678